Chiffres en millions de dollars américains. L'exercice financier va de février à janvier.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenus
2,288
2,001
1,373
12
746
848
Croissance des revenus (H/H)
42%
46%
11,342%
-98%
-12%
-81%
Coût des ventes
2,002
1,810
1,330
5
698
774
Bénéfice brut
286
190
43
7
48
74
Vente, Général et Administration
255
283
370
265
419
448
Recherche et développement
--
--
--
--
--
--
Frais d'exploitation
-863
1,102
607
747
1,003
1,340
Autres revenus (charges) non opérationnels
--
--
--
--
--
--
Bénéfice avant impôts
748
745
3,701
-1,424
-409
-2,410
Charge d'impôt sur le revenu
-23
-23
-42
-46
25
22
Bénéfice net
772
769
4,224
-1,443
-400
-2,429
Croissance du bénéfice net
-81%
-82%
-393%
261%
-84%
128%
Actions en circulation (diluées)
8,907.4
26,196.43
14,080.16
8,907.4
8,907.4
8,507.94
Variation des actions (H-H)
0%
86%
57.99%
0%
5%
24%
EPS (dilué)
0.08
0.02
0.3
-0.14
-0.04
-0.28
Croissance du EPS
-83%
-90%
-305%
225%
-84%
84%
Flux de trésorerie libre
108
76
-94
-94
-501
-43
Flux de trésorerie libre par action
--
--
--
--
--
--
Marge brute
12.5%
9.49%
3.13%
58.33%
6.43%
8.72%
Marge opérationnelle
50.26%
-45.52%
-41.07%
-6,158.33%
-128.01%
-149.29%
Marge bénéficiaire
33.74%
38.43%
307.64%
-12,025%
-53.61%
-286.43%
Marge du flux de trésorerie libre
4.72%
3.79%
-6.84%
-783.33%
-67.15%
-5.07%
EBITDA
1,293
-683
-259
-409
-553
-810
Marge EBITDA
56.51%
-34.13%
-18.86%
-3,408.33%
-74.12%
-95.51%
D&A pour le résultat opérationnel
143
228
305
330
402
456
EBIT
1,150
-911
-564
-739
-955
-1,266
Marge EBIT
50.26%
-45.52%
-41.07%
-6,158.33%
-128.01%
-149.29%
Taux d'imposition effectif
-3.07%
-3.08%
-1.13%
3.23%
-6.11%
-0.91%
Statistiques clés
Clôture préc.
$0.005
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
$0.005 - $0.01
Volume
--
Volume moyen
0
BPA (TTM)
0.00
Rendement en dividend
--
Capitalisation boursière
$83.9M
Qu’est-ce que GBCMF ?
Global Bio-chem Technology Group Co. Ltd. is an investment holding company, which engages in the manufacture and sale of corn refined and corn-based biochemical products. The company employs 1,492 full-time employees The company went IPO on 2001-03-16. The Amino Acids segment is engaged in the manufacture and sales of corn-based amino acids products, including lysine and threonine. The Upstream Products segment is engaged in the manufacture and sales of corn starch, gluten meal, corn oil and other corn refined products. The Corn Sweeteners segment is engaged in the manufacture and sales of corn-based sweeteners products, including glucose, maltose, high fructose corn syrup, crystallized glucose and maltodextrin. The Polyol Chemicals segment is engaged in the manufacture and sales of corn-based biochemical products, including polyol chemicals, anti-freeze products, hydrogen and ammonia.